Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Hepatic Manifestations of Inflammatory Bowel Disease.

Literature DB >> 33968391

Hepatic Manifestations of Inflammatory Bowel Disease.

Parita Patel¹, Sushila Dalal¹.

Abstract

Entities: Disease

Year: 2021 PMID： 33968391 PMCID： PMC8087932 DOI： 10.1002/cld.1046

Source DB: PubMed Journal: Clin Liver Dis (Hoboken) ISSN： 2046-2484

Keyword Cloud
References

× No keyword cloud information.

17 in total

1. Small-duct primary sclerosing cholangitis: a long-term follow-up study.

Authors: Paul Angulo; Yaakov Maor-Kendler; Keith D Lindor
Journal: Hepatology Date: 2002-06 Impact factor: 17.425

2. EASL Clinical Practice Guidelines: management of cholestatic liver diseases.

Authors:
Journal: J Hepatol Date: 2009-06-06 Impact factor: 25.083

3. Screening for Nonalcoholic Fatty Liver Disease in Inflammatory Bowel Diseases: A Cohort Study Using Transient Elastography.

Authors: Chiara Saroli Palumbo; Sophie Restellini; Che-Yung Chao; Achuthan Aruljothy; Carolyne Lemieux; Gary Wild; Waqqas Afif; Peter L Lakatos; Alain Bitton; Sila Cocciolillo; Peter Ghali; Talat Bessissow; Giada Sebastiani
Journal: Inflamm Bowel Dis Date: 2019-01-01 Impact factor: 5.325

4. Diagnosis and management of primary sclerosing cholangitis.

Authors: Roger Chapman; Johan Fevery; Anthony Kalloo; David M Nagorney; Kirsten Muri Boberg; Benjamin Shneider; Gregory J Gores
Journal: Hepatology Date: 2010-02 Impact factor: 17.425

Review 5. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases.

Authors: Naga Chalasani; Zobair Younossi; Joel E Lavine; Michael Charlton; Kenneth Cusi; Mary Rinella; Stephen A Harrison; Elizabeth M Brunt; Arun J Sanyal
Journal: Hepatology Date: 2017-09-29 Impact factor: 17.425

Hepatic Manifestations of Inflammatory Bowel Disease.

1. Small-duct primary sclerosing cholangitis: a long-term follow-up study.

2. EASL Clinical Practice Guidelines: management of cholestatic liver diseases.

3. Screening for Nonalcoholic Fatty Liver Disease in Inflammatory Bowel Diseases: A Cohort Study Using Transient Elastography.

4. Diagnosis and management of primary sclerosing cholangitis.

Review 5. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases.

6. Abnormal hepatic biochemistries in patients with inflammatory bowel disease.

7. A unique clinical phenotype of primary sclerosing cholangitis associated with Crohn's disease.

8. Primary sclerosing cholangitis, autoimmune hepatitis, and overlap in Utah children: epidemiology and natural history.

Review 9. Primary sclerosing cholangitis associated with inflammatory bowel disease: an update.

10. The natural history of small-duct primary sclerosing cholangitis.